The widely used chemotherapy drug Taxol does not work for the most common form of breast cancer and helps far fewer patients than has been believed, surprising new research suggests. If further study ...

During and after chemotherapy, nearly half of cancer patients endure circadian rhythm disruptions, which worsens treatment ...

Nearly half of cancer patients suffer circadian rhythm disruptions during chemotherapy, worsening side effects.

Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study The study was prematurely concluded after a futility ...

Abstract Purpose: Preoperative chemotherapy is the conventional primary treatment in locally advanced breast cancer (LABC). We investigated the safety and efficacy of primary twice-weekly paclitaxel ...

The ROSELLA trial showed relacorilant plus nab-paclitaxel improved progression-free survival in platinum-resistant ovarian cancer patients. Relacorilant reduced disease progression risk by 30% and ...

The first trial of adjuvant platinum-based chemotherapy plus paclitaxel in patients with high-risk penile cancer provided some insights. Adjuvant platinum-based chemotherapy plus paclitaxel ...

The FDA has accepted a new drug application for relacorilant as a treatment for patients with platinum-resistant ovarian ...

Dr. Lisa Carey answers the question: 'Drugs, Schedules For Chemo Treatments?' — -- Question: What kinds of drugs, timetables and possible side effects can be expected with the following commonly ...

University of Arizona researchers devised a new method to deliver cancer chemotherapy drugs to pancreatic and breast cancer tumors more effectively and with less damage to healthy tissues than ...